Junxian Yu
Impact in
- Pharmacology top 5%
- Alkaloids: synthesis and pharmacology
- Berberine and alkaloids research
- Pharmacological Effects of Natural Compounds
-
- Traditional Chinese Medicine Analysis
Papers in
-
- Cancer-related gene regulation 3
- Protein Degradation and Inhibitors 2
- Oncology 14
- Cancer Immunotherapy and Biomarkers 6
- Pancreatic and Hepatic Oncology Research 3
- Co-authors
- Xiuping Chen (1 shared paper)Bangwei Cao (6 shared papers)Jingshan Shi (1 shared paper)Jun Wu (2 shared papers)Qin Li (4 shared papers)Fang Geng (2 shared papers)Hang Yin (2 shared papers)Zheng Wang (1 shared paper)
- Journals
- EBioMedicine (3 papers)PLoS ONE (2 papers)OncoTargets and Therapy (2 papers)Advanced Science (2 papers)Biomedicine & Pharmacotherapy (2 papers)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Junxian Yu
35 papers receiving 628 citations
Peers
Comparison fields: 5 of 98
- Pharmacology 111
- Complementary and alternative medicine 46
- Cancer Research 81
- Pharmacology 84
- Oncology 129
Countries citing papers authored by Junxian Yu
This map shows the geographic impact of Junxian Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junxian Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junxian Yu more than expected).
Fields of papers citing papers by Junxian Yu
This network shows the impact of papers produced by Junxian Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junxian Yu. The network helps show where Junxian Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Junxian Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pharmacological actions of Uncaria alkaloids, rhynchophylline and isorhynchophylline. | 2003 | 144 |
| 2 | 2017 | 88 | |
| 3 | 2016 | 81 | |
| 4 | 2018 | 62 | |
| 5 | 2018 | 39 | |
| 6 | 2015 | 21 | |
| 7 | 2021 | 16 | |
| 8 | 2023 | 15 | |
| 9 | 2019 | 13 | |
| 10 | 2017 | 12 | |
| 11 | 2008 | 12 | |
| 12 | 2017 | 11 | |
| 13 | 2023 | 11 | |
| 14 | 2023 | 10 | |
| 15 | 2016 | 10 | |
| 16 | 2022 | 9 | |
| 17 | 2013 | 9 | |
| 18 | 2017 | 9 | |
| 19 | 2020 | 8 | |
| 20 | 2023 | 7 |
About Junxian Yu
Junxian Yu is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Surgery, having authored 37 papers that have together received 636 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Treatments and Mutations (4 papers), Bioactive Compounds and Antitumor Agents (3 papers), Cancer-related gene regulation (3 papers), Autophagy in Disease and Therapy (3 papers), Ferroptosis and cancer prognosis (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Pharmacology (111 citations), Complementary and alternative medicine (46 citations), Cancer Research (81 citations), Pharmacology (84 citations) and Oncology (129 citations). Junxian Yu has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Xiuping Chen, Bangwei Cao, Jingshan Shi, Jun Wu, Qin Li, Fang Geng, Hang Yin, Zheng Wang, Manyuan Wang and Jing Wang. Their work appears in journals such as EBioMedicine, PLoS ONE, OncoTargets and Therapy, Advanced Science and Biomedicine & Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.